Menu Search
Equities

Munar Pharma SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
8YX:FRA

Munar Pharma SA

Actions
  • Price (EUR)0.0374
  • Today's Change0.001 / 3.31%
  • Shares traded1.00k
  • 1 Year change--
  • Beta0.8043
Data delayed at least 15 minutes, as of Feb 06 2026 14:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Munar Pharma SA, formerly Munar SA, is a Poland-based company engaged in the information technology (IT) and pharmaceutical sectors. The Company is focusing on publishing and porting games and its' activity is directed towards finding computer game projects in the final phase of implementation, supporting developers in their production (including financing), and then publishing games (and actively promoting and marketing them) on digital platforms and retail sales on international markets. The Company focuses on both amateur groups and professional studios and mainly targets establishing cooperation with entities from the gaming industry and business environment institutions from Poland as well as from abroad. The Company is working on a strategy to focus its activities on the pharmaceutical sector.

  • Revenue in PLN (TTM)0.00
  • Net income in PLN-667.65k
  • Incorporated2008
  • Employees4.00
  • Location
    Munar Pharma SAul. Lindleya 16WARSZAWA 02-013PolandPOL
  • Phone+48 895320606
  • Fax+48 895320606
  • Websitehttps://munar.pl/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.